US FDA Commissioner Scott Gottlieb announced a coordinated strategy to remove regulatory ambiguity from the burgeoning field of digital health and keep agency device reviewers' hands off new software and mobile apps in as many cases as possible.
Gottlieb outlined his broad-strokes vision in a June 15 blog post, highlighting a plan to implement the software provisions in...





